SGS Life Science Services Becomes a Medidata Raver Accredited Partner

November 12, 2014
Company News Release

SGS Life Science Services announced that its Biometrics group became a Medidata Rave accredited partner.

SGS Life Science Services, the leading pharmaceutical clinical and bioanalytical contract solutions provider, today announced that its Biometrics group, one of the largest European data management, statistics and medical writing teams, became a Medidata Rave® accredited partner. Medidata Rave is the industry-leading system for capturing, managing and reporting clinical research data, designed to help life science companies optimize their research investments, by efficiently streamlining the clinical trial process.

Medidata’s accreditation program for Rave is an in-depth qualification program through both build and process enablement tracks, with the aim for partners to provide end-user training, user and site administration, study build, reporting, outputs and migration services. Implementing Rave studies since 2010, and a Medidata CTMS™ partner for more than five years, SGS Life Science Services has robust and fully optimized processes in place, allowing for short set-up timelines that support the clinical team’s challenge of getting First Patient In (FPI) on time.

“Medidata Rave provides unmatched capabilities for complex designs that we manage in today’s oncology and infectious disease programs, as well as when implementing targeted SDV,” explained Luc Braeken, Business Unit Manager Biometrics & Medical Affairs, SGS Life Science Services. “We find that our sponsors benefit greatly from data collection in Medidata Rave, with efficient data conversion to CDISC SDTM compliant datasets at the SGS Data Management center. Our goal is to empower our clients with full visibility on the study data at any moment via the eCRF, progress reports indicating the cleaning status and the CDISC SDTM datasets, which can be delivered soon after FPI.”

“Medidata Rave is a well-known system by many sites, allowing immediate data entry from FPI onwards without the hurdles and learning curve that are typically experienced with less-known EDC systems,” said Joris De Bondt, Head EDC and Data Standards, SGS Life Science Services. “As a Medidata Rave accredited partner, SGS Life Science Services can offer the best, most innovative technology for clinical trials with a superior site experience. Our eCRF designers now have access to configurable work flows, sophisticated eCRF design, simple and complex edit checking and straight-forward integrations for a wide variety of data sources.”

Steve Heath, Medidata’s Head of Channel Sales, added: “Medidata’s industry-leading cloud platform of innovative technology and data analytics is transforming clinical development today—helping make clinical trials more cost effective, faster and safer. Our accreditation process assures life science companies are working with service partners that are fully equipped to use Medidata technology for optimal trial performance.”

With 21 laboratories offering contract analytical and bioanalytical services, SGS leverages its wholly-owned global network, present in North America, Europe, and Asia, to deliver harmonized solutions to large pharmaceutical and biotechnology firms. In addition to testing services for the bio/pharmaceutical market, SGS also provides Phase I to IV clinical trial management and services encompassing data management and statistics, PK/PD modeling and simulation, pharmacovigilance and regulatory consultancy.